David retweeted
Plano Company @ActinideInc creates breakthrough particle accelerator that produces material crucial to prostate cancer drug, Pluvicto. It also can be reconfigured to enrich uranium. CEO @EricOlsz says this can reduce American 🇺🇸 Dependence on Russia for critical materials @FOX4
We’re back. On today's show:
- @jordanschneider (ChinaTalk)
- @stephenbalaban (Lambda)
- @EricOlsz (Actinide)
- @atomicallypure (Actinide)
- @billythalheimer (Regent)
- @AaronLCannon (Outset AI)
See you on the stream.
WE'RE BACK: Meta Addiction, Jalapeño, Tim Cook's Last Day, Flocked xitter.cf/i/broadcasts/1mGPaZplm…
David retweeted
In just a few weeks, we succeeded in producing HALEU - a critical material with a multi-year waitlist.
The recovered HALEU was produced in research quantities under the laboratory-scale exclusion in NRC regulations and was verified to be 15.38% enriched by an independent ISO/IEC 17025-accredited lab - well within the 5-20% qualifier for HALEU.
David retweeted
This week, @ActinideInc became the first startup in history to enrich uranium, producing HALEU, the fuel for next-gen and small modular reactors.
We did it using Endurance, a particle accelerator that we designed and built in Texas.
Endurance usually produces enriched Yb-176, a precursor for cancer therapies worth roughly $30,000 per gram.
After a bulk Yb-176 delivery on July 30, we reconfigured Endurance for uranium.







